Yimao Wu1,2,#, Yitong Liu2,#, Ruowei Sun3,#, Yiyuan Zhang2, Qian Zhang4,*, Chen Li5,*, Mengyao Li1,6,*
Oncology Research, Vol.34, No.3, 2026, DOI:10.32604/or.2026.075012
- 24 February 2026
Abstract Tumor metabolic reprogramming is a core hallmark of cancer, characterized by pathways such as aerobic glycolysis, aberrant lipid metabolism, and glutaminolysis that support rapid proliferation and immunosuppressive microenvironments. Circular RNAs (circRNAs) are highly stable, evolutionarily conserved non-coding RNAs that have emerged as critical modulators of these metabolic shifts. This review aims to systematically elucidate the roles and mechanisms of circRNAs in reprogramming tumor metabolism, and to discuss their clinical potential as biomarkers and therapeutic targets. Through mechanisms including miRNA sponging, protein interactions, regulation of mitochondrial dynamics, and modulation of metabolic enzymes, circRNAs influence key metabolic… More >